← Leaderboards
Etty N. Benveniste
University Of Alabama At Birmingham
$18,164,533
Attributed
$18,454,840
Total exposure
18
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,356,819 · 19
By mechanism
R01$13,411,756 · 9
T32$2,019,320 · 1
P50$1,979,144 · 2
P01$1,360,717 · 3
R21$354,417 · 1
P20$192,940 · 1
Top collaborators
- Jerzy P Szaflarski1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Gordon P. Meares$3,693,137
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineGene ExpressionMacrophageResponseSignal TransductionPathway InteractionsMicrogliaCellsInterleukin-6ImmuneSignal PathwayInflammationAffectBrainJak2 GeneIn VivoTranscription FactorProductionRegulationAstrocytesGenesPhenotypeChemokineMultiple Sclerosis
Grant awards (73)
Neuroimaging of Neuroinflammation in Temporal Lobe Epilepsy$580,614
R01 · FY2025 · NS
Project 2: Validating the JAK/STAT Pathway as a Novel Therapeutic Strategy in PD$379,862
P50 · FY2022 · NS · contact PI
Project 2: Validating the JAK/STAT Pathway as a Novel Therapeutic Strategy in PD$379,862
P50 · FY2021 · NS · contact PI
Project 2: Validating the JAK/STAT Pathway as a Novel Therapeutic Strategy in PD$381,870
P50 · FY2020 · NS · contact PI
The Role of CK2 in Glioblastoma Development$336,263
R01 · FY2020 · CA · contact PI
Project 2: Validating the JAK/STAT Pathway as a Novel Therapeutic Strategy in PD$74,796
P50 · FY2020 · NS · contact PI
Project 2: Validating the JAK/STAT Pathway as a Novel Therapeutic Strategy in PD$379,863
P50 · FY2019 · NS · contact PI
The Role of CK2 in Glioblastoma Development$326,174
R01 · FY2019 · CA · contact PI
Project 2: Validating the JAK/STAT Pathway as a Novel Therapeutic Strategy in PD$382,891
P50 · FY2018 · NS · contact PI
The Role of CK2 in Glioblastoma Development$336,263
R01 · FY2018 · CA · contact PI
The Role of CK2 in Glioblastoma Development$338,830
R01 · FY2017 · CA · contact PI
Therapeutic Intervention of the JAK/STAT Pathway for Neuroinflammation$321,563
R01 · FY2017 · NS · contact PI
Training Program in Brain Tumor Biology$56,780
T32 · FY2017 · NS · contact PI
The Role of CK2 in Glioblastoma Development$348,244
R01 · FY2016 · CA · contact PI
Therapeutic Intervention of the JAK/STAT Pathway for Neuroinflammation$321,563
R01 · FY2016 · NS · contact PI
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma$303,988
R01 · FY2016 · CA · contact PI
Training Program in Brain Tumor Biology$187,158
T32 · FY2016 · NS · contact PI
Validation of the JAK/STAT Signaling Pathway in PD$96,470
P20 · FY2016 · NS · contact PI
Therapeutic Intervention of the JAK/STAT Pathway for Neuroinflammation$321,563
R01 · FY2015 · NS · contact PI
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma$303,988
R01 · FY2015 · CA · contact PI
Training Program in Brain Tumor Biology$189,992
T32 · FY2015 · NS · contact PI
Validation of the JAK/STAT Signaling Pathway in PD$96,470
P20 · FY2015 · NS · contact PI
Therapeutic Intervention of the JAK/STAT Pathway for Neuroinflammation$318,346
R01 · FY2014 · NS · contact PI
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma$294,868
R01 · FY2014 · CA · contact PI
Training Program in Brain Tumor Biology$252,216
T32 · FY2014 · NS · contact PI
Therapeutic Intervention of the JAK/STAT Pathway for Neuroinflammation$321,471
R01 · FY2013 · NS · contact PI
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma$285,749
R01 · FY2013 · CA · contact PI
Training Program in Brain Tumor Biology$246,618
T32 · FY2013 · NS · contact PI
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma$303,988
R01 · FY2012 · CA · contact PI
Expression and Function of SOCS Proteins in Glial Cells$248,675
R01 · FY2011 · NS · contact PI
Training Program in Brain Tumor Biology$134,087
T32 · FY2011 · NS · contact PI
Expression and Function of SOCS Proteins in Glial Cells$251,213
R01 · FY2010 · NS · contact PI
Training Program in Brain Tumor Biology$226,648
T32 · FY2010 · NS · contact PI
TRADD as a Regulator of Cytokine Signaling in Glia$287,130
R01 · FY2009 · NS · contact PI
Expression and Function of SOCS Proteins in Glial Cells$242,750
R01 · FY2009 · NS · contact PI
Training Program in Brain Tumor Biology$229,681
T32 · FY2009 · NS · contact PI
TRADD as a Regulator of Cytokine Signaling in Glia$125,159
R01 · FY2009 · NS · contact PI
Expression and Function of SOCS Proteins in Glial Cells$81,713
R01 · FY2009 · NS · contact PI
TRADD as a Regulator of Cytokine Signaling in Glia$287,130
R01 · FY2008 · NS · contact PI
Training Program in Brain Tumor Biology$276,905
T32 · FY2008 · NS · contact PI
Expression and Function of SOCS Proteins in Glial Cells$253,750
R01 · FY2008 · NS · contact PI
CD40 Expression and Function in Microglia$293,877
R01 · FY2007 · NS · contact PI
TRADD as a Regulator of Cytokine Signaling in Glia$287,130
R01 · FY2007 · NS · contact PI
Training Program in Brain Tumor Biology$219,235
T32 · FY2007 · NS · contact PI
The Role of ING4 in Modulating the Tumorigenic Contribution of NF-kB in Gliomas$190,729
R21 · FY2007 · NS · contact PI
CD40 Expression and Function in Micorglia$302,654
R01 · FY2006 · NS · contact PI
TRADD as a Regulator of Cytokine Signaling in Glia$295,705
R01 · FY2006 · NS · contact PI
The Role of ING4 in Modulating the Tumorigenic Contribution of NF-kB in Gliomas$163,688
R21 · FY2006 · NS · contact PI
CD40 Expression and Function in Micorglia$309,938
R01 · FY2005 · NS
TRADD as a Regulator of Cytokine Signaling in Glia$302,302
R01 · FY2005 · NS
CYTOKINE REGULATION OF CIITA AND CLASS II MHC IN GLIA$310,010
R01 · FY2004 · NS
CD40 Expression and Function in Micorglia$309,938
R01 · FY2004 · NS
REGULATION OF IL-6 EXPRESSION IN ASTROCYTES$287,000
R01 · FY2004 · NS
CXCR4 Expression and Function in Astrocytes$215,250
R01 · FY2004 · MH
CYTOKINE REGULATION OF CIITA AND CLASS II MHC IN GLIA$310,384
R01 · FY2003 · NS
CD40 Expression and Function in Microglia$309,938
R01 · FY2003 · NS
REGULATION OF IL-6 EXPRESSION IN ASTROCYTES$287,000
R01 · FY2003 · NS
CXCR4 Expression and Function in Astrocytes$215,250
R01 · FY2003 · MH
CYTOKINE REGULATION OF CIITA AND CLASS II MHC IN GLIA$310,749
R01 · FY2002 · NS
REGULATION OF IL-6 EXPRESSION IN ASTROCYTES$287,000
R01 · FY2002 · NS
CXCR4 Expression and Function in Astrocytes$215,250
R01 · FY2002 · MH
FASEB Summer Conference on Neuroimmunology$26,875
R13 · FY2002 · AG
Interferon-mediated suppression of MMP-9 gene expression and function in gliomas$0
P50 · FY2002 · CA
CYTOKINE REGULATION OF CIITA AND CLASS II MHC IN GLIA$311,102
R01 · FY2001 · NS
REGULATION OF IL-6 EXPRESSION IN ASTROCYTES$287,000
R01 · FY2001 · NS
CXCR4 Expression and Function in Astrocytes$215,250
R01 · FY2001 · MH
ICAM-1 GENE EXPRESSION IN MALIGNANT GLIAL TUMORS$0
P01 · FY2001 · NS
MOLECULAR IMMUNOPATHOGENESIS OF DEMYELINATING DISEASE$901,979
P01 · FY2000 · NS
CYTOKINE REGULATION OF CIITA AND CLASS II MHC IN GLIA$321,034
R01 · FY2000 · NS
REGULATION OF IL-6 EXPRESSION IN ASTROCYTES$287,000
R01 · FY2000 · NS
ICAM-1 GENE EXPRESSION IN MALIGNANT GLIAL TUMORS$232,605
P01 · FY2000 · NS
INTRACELLULAR ADHESION MOLECULE-1 REGULATION AND FUNCTION IN GLIAL CELLS$226,133
P01 · FY2000 · NS
FASEB SUMMER CONFERENCE ON NEUROIMMUNOLOGY$11,650
R13 · FY2000 · AG